bluebird bio Inc
(LTS:0HOH)
$
0.5004
0.0109 (2.23%)
Market Cap: 96.39 Mil
Enterprise Value: 342.75 Mil
PE Ratio: 0
PB Ratio: 1.82
GF Score: 29/100 bluebird bio Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript
Sep 18, 2020 / 02:05PM GMT
Release Date Price:
$57.04
Jason Matthew Gerberry
BofA Merrill Lynch, Research Division - MD in US Equity Research
All right. Good morning. Good afternoon, everybody. Thanks for joining us at -- for the next company presenter at the Bank of America Global Healthcare Conference. I'm thrilled to be introducing our next company presenter, bluebird bio, a biotechnology company focused on gene and cell therapies. Just by way of background, I cover SMID-cap biotech at Bank of America. So I'm pleased to be introducing -- or moderating today's fireside chat with Chip Baird, CFO; and David Davidson, Chief Medical Officer.
So gentlemen, first off, thank you for joining us today.
David M. Davidson
bluebird bio, Inc. - Chief Medical Officer
Our pleasure, Jason.
William D. Baird
bluebird bio, Inc. - CFO
Yes. Thanks for having us.
Questions & Answers
Jason Matthew Gerberry
BofA Merrill Lynch, Research Division - MD in US Equity Research
Yes, of course, of course. So I
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot